chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pains starting the day after getting the shot.  Chest pains coming and going for 2 weeks and still occurring.  Left should has remained sore for 3 weeks after getting the shot.  I've felt like I was on the cusp of a heart attack while playing hockey and have never had this feeling in my life having played hockey regularly for the last 30 years.   I've had nose bleeds the last couple of weeks as well.
Information has been received from a registered nurse concerning an adult patient who was vaccinated with a dose of Varivax (site unknown). Subsequently the patient failed to seroconvert. It was reported to be unknown if the patient sought medical attention. Additional information has been received.
Stomach very sick 24 hours after vaccine. 8 days after vaccine I got ?COVID Arm? still have itchy rash  this is day 3
Pt. experience muscle pain at injection site that haven't subside up to 10/11/17.
Five minutes after vaccine administration, patient reported feeling dizzy. Provided apple juice and snack, quiet place to sit. BP 122/88, P 88. While seated reported shakiness, observable to bilateral limbs, diminished when patient engaged in conversation. Then reported onset of 5/10 pain from headache. Patient reports history of anxiety. Parents notified and picked up patient. Advised to follow up with patient's medical provider and to report any increase or change in SX immediately, utilize emergency services PRN. Parent verbalizes understanding. Patient able to rise to standing and ambulated without difficulty when exiting clinic.
Moderna booster shot- 5 days after vaccination developed transient rash continuing at least until 8 days. Mainly on trunk and arms. Reddish skin discoloration, will appear and disappear in various places.
No adverse event; second dose <35 days after first dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose <35 days after first dose) and NO ADVERSE EVENT (No adverse event) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose <35 days after first dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose <35 days after first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose <35 days after first dose).    Concomitant products were not reported.  It was reported that patient did not had any other boosters. On 27-Oct-2022 patient went for new booster dose.  Treatment medications were not reported.
the following day after taking the vaccine she notice that evening a swelling on left side of her neck with a lump
I had a breakthrough case of Covid-19 I lost my taste for about a day, then I had cold like symptoms with a lot of congestion
Resident began to have nausea and a slight rash on her arms and chest. Resident's doctor was notified and new orders given  for Benadryl 25mg po BIDx 3 days and Zofran administered. Nausea and rash subsided
Itching of hands & feet on the bottoms; vomiting, diarrhea & very sleepy; given Ceclor; pt had ceclor only & got sick; poss ceclor & vax are now interacting to cause a problem; 10JAN93 hives;
I had my first dose of the Moderna vaccine on Feb. 10, 2021. I had about three days of chills, aches, headache, very sore arm. etc. On Feb. 22,2021 a red area  about 3 or 4 inches around the site of the injection was noticed. It was itchy and uncomfortable. I spoke to my internist and allergist. There is some disagreement about whether I should take the second dose.  I have taken benadryl and tylenol. Both doctors said it was unusual for such a reaction 2 days after receiving the vaccine. What information do you have about rashes occurring so long after the vaccination? What is the recommendation about the second vaccine? Thank you.
pt recv vax & exp erythematous, urticarial rash on arms & legs;pt assoc the rash w/attending a tanning salon;pt had visited the salon a/ w/o any outbreak of rash & wondered whether tanning & vax may have precipitated the rash;
Next day, my lips swelled, upper and lower, and rash and small bumps broke out under lower lip
neck swollen glands; chills (high layers on); 2 hours after with a temperature of 102F (from the normal 97); chest pain; very weak; arm hurt at night time; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (2 hours after with a temperature of 102F (from the normal 97)), CHEST PAIN (chest pain), ASTHENIA (very weak), LYMPHADENITIS (neck swollen glands) and CHILLS (chills (high layers on)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced MYALGIA (arm hurt at night time). On 22-Apr-2021, the patient experienced BODY TEMPERATURE INCREASED (2 hours after with a temperature of 102F (from the normal 97)), CHEST PAIN (chest pain), ASTHENIA (very weak) and CHILLS (chills (high layers on)). On an unknown date, the patient experienced LYMPHADENITIS (neck swollen glands). At the time of the report, BODY TEMPERATURE INCREASED (2 hours after with a temperature of 102F (from the normal 97)), CHEST PAIN (chest pain), ASTHENIA (very weak), LYMPHADENITIS (neck swollen glands), CHILLS (chills (high layers on)) and MYALGIA (arm hurt at night time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details were not provided   This case was linked to MOD-2021-086022 (Patient Link).
Early onset of menstrual period with unusually heavy bleeding. I also had chills and fever within 24 hours of the vaccine and redness at the injection site.
Patient received 4th booster dose on 4//15/22 but presented to vaccine clinic requesting a booster.  Agency and vaccine card had conflicting information due to some providers not reporting doses.  Administered another booster on 6/7/22
Small local rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Small local rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 48A21A and 030M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for Vitamin supplementation.   On 25-Feb-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE RASH (Small local rash). On 07-Mar-2021, VACCINATION SITE RASH (Small local rash) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable.  No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-117037, MOD-2021-036644 (Patient Link).
101 fever for 2 days now down to 99 fever very bad muscular pain for 2 days and still happening intense headache unable to sit due to back pain could not sleep due to pain left underarm is VERY swollen
Approx 6 hrs after vaccine administered, pt c/o "flushing" - redness to face and neck.
During 15 minute observation period patient noted a headache and a general feeling of weakness.  Denied SOB, rash, feeling of throat swelling.  Was offered water and a snack which overall improved symptoms.  Vital signs all stable.  No medication intervention was used.  Patient left clinic feeling well and on recognizance
Case number PHHY2011US32267 is a combined initial and follow-up spontaneous report received on 15 Apr 2011. This report refers to a 15 years old female patient. She was vaccinated with meningococcal vaccine (manufacturer and batch number unknown) on an unspecified date, when she was 12 years old and was given another shot of MENVEO vaccine (batch number: M100130) intramuscularly on 11 Apr 2011. On the same day of vaccination she experienced vomiting, fatigue and headache. The outcome of the event was reported as condition unchanged as of 14 Apr 2011. Following internal review of the data received on 15 Apr 2011, the following significant correction was done on 11 May 2011: The event "inappropriate schedule of vaccine administered" was deleted.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022).    No concomitant medication information was provided.  The reporter administered the vaccine to the patient after the 30 day by used.  Patient received half dose.  The vial was initially stored in refrigerator on 04-Jun-2022.  The vial did not undergo any temperature excursions.  No treatment drug details was reported.
Systemic: Chills-Severe, Systemic: Exhaustion-Severe, Systemic: Other- rash on tongue as ulcers, swelling of right side of face, dizziness,fatigue, sent to  ER-Severe; symptoms  lasted  1  day.
The next morning he work up with symptoms of vertigo.  He was dizzy with ambulating and with going up and down stairs.  He missed school for 3 days and altogether it lasted 6-7 days.  Was seen by his pediatrician who agreed this was likely due to vaccine.  Had a recurrence of the episode on 1/28/23 which resolved after two days Third and final episode was 2/10/23 and resolved in a day.
A healthcare professional reported that he received a dose of influenza virus vaccine (manufacturer unknown) in November, 2002.  he subsequently developed hives which have persisted for the past 8 weeks.  He was seen by his physician who prescribed Zyretec which has improved but not resolved this condition.  At the date of the report no further information was available.
Leg pains at night, left arm pain (injection arm), fatigue for four days after first dose of Pfizer.
first Shingrix vaccine in October of 2020/ has not received second dose; Shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In July 2021, between 8 and 10 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received his first dose of shingrix vaccine and got shingles in early July 2021. Till nowpatient had not received his second dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to followup.
This spontaneous report was received from a patient's mother and refers to a 6 year old female patient. No information about the patient's pertinent medical history, concomitant medications and concurrent conditions was provided. On an unknown date, the patient was vaccinated with a first dose of VARIVAX (strength, route of administration, lot# and expiration date were not reported). After the vaccination the patient had no adverse reactions. On 31-MAY-2018 the patient was vaccinated with a second dose of VARIVAX injection, 0.5 ml (route of administration, lot# and expiration date were not reported) for prophylaxis. By the time they got to the car, the patient started crying. The patient's chest was burning and she started coughing. The patient's throat, mouth, tongue and throat hurt and the patient started holding her throat. Pain in throat lasted for 20 minutes and then resolved. The patient also had an injection site reaction, that was a hard red circle, that was about 3/4 of an inch across. The patient's mother stated, that the injection site reaction has resolved but she didn't say when it resolved. The outcome of the other events was reported as recovered/resolved (on an unknown date in 2018). Causality assessment was not provided.
At 24 hrs post receiving vaccines mom noticed redness, swelling, heat and bruising over upper L arm. Tender to touch. Seen in PCP office, measured. Tx with Benadryl, cold compresses. Follow up call made to mom next day.
Ringing in ears will not stop; This is a spontaneous report received from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), as a single dose via unspecified route of administration on 12Mar2021 at 14:45 (at the age of 59-year-old at vaccination) for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. The patient did not had any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. The patient experienced ringing in ears, which would not stop on an unspecified date. No Therapeutic measures taken for the adverse event ringing in ears. At the time of report, the outcome of the event ringing in ears was not recovered. Information about lot/batch number cannot be obtained. No further information is expected.
no additional AE's were reported; the patient was administered a dose of VAQTA after it expired; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported.  On 20-JAN-2023, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 ml, lot #W007375, expiration date: 16-JAN-2023, intamuscularly (anatomical location was not provided) administered for prophylaxis (Expired product administered). No additional adverse event (AE) details were provided and no additional AEs were reported (No adverse event).
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 13Jun2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: COVID 19 Treatment; (04Jun2022) Negative, notes: Resolution of symptoms at day 5, RAT negative; (13Jun2022) Positive, notes: recrudescence of symptoms more severe than initial symptoms at day 14, RAT positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient did not receive other medication in 2 weeks. The patient was treated with Paxlovid, treatment start date: 31May2022 and treatment stop date: 04Jun2022. for COVID-19. The patient had no known allergies. Paxlovid Rebound. Resolution of symptoms at day 5, RAT negative, recrudescence of symptoms more severe than initial symptoms at day 14, RAT positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided, known drug safety profile and plausible temporal association, the causality between BNT162B2 and the events Drug ineffective and COVID-19 cannot be completely excluded.
PM of vaccine, horrible chills all PM. All day the following day, aches and pains, headache. By Friday PM, all symptoms gone.
Shortness of breath because extreme in late March/Early April.  X-Ray and Cat-scan showed serious new inflammation in lungs and expanded bronchiectasis.  Sample taken by bronchoscopy showed pseudomonas infection not susceptible to oral antibiotics.  Treatment was a week of Cefemime injections three times a day.
Large local reaction - swelling & redness of entire upper arm (L) from shoulder to elbow - started about 24 hours after vaccination.
Chills, pounding headache, low grade fever of 99.6, and rashes on injection site
Swelling of lymph node by collar bone on left side. swelling and lumps on left breast and pain. difficult to turn neck and look left. progressively getting worse
Elevated waking fasting blood glucose.   Average 1/1/2021-4/6/2021 = 98 mg/dl Average 4/7/2021-5/7/2021 = 111 Average 5/8/2021-7/8/2021 = 98
Headache, body aches, chills, redness on arm past injection site, knot in arm at same area.
Inadvertently gave 0.5cc H1N1 in left deltoid and right deltoid. Patient area 1 to 1 1/2 hr. No adverse reaction noted during this time.
Severe vomiting, mild dehydration. Surgical consult, GI consult = neg findings.  11/19/2007 MR received for o/n observation 10/19-20/2007 with D/C DX: Emesis. Child presented to ER with 10-12 episodes of emesis over a 12 hour period.  Decreased po intake.  PE WNL. Surgery consult: surgical cause of emesis unlikely. No further emesis during admission.
pt recv vax 5MAY95 & 2JUN96 pt exp chicken pox w/20-27 lesions distributed on trunk, face, & arms; a fever of about 100 degrees;runny nose;
fatigue; Little achy; Little nausea; Low grade fever; feeling abnormal; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), PAIN (Little achy), NAUSEA (Little nausea), PYREXIA (Low grade fever) and FEELING ABNORMAL (feeling abnormal) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced FATIGUE (fatigue), PAIN (Little achy), NAUSEA (Little nausea), PYREXIA (Low grade fever) and FEELING ABNORMAL (feeling abnormal). On 10-Mar-2021, FATIGUE (fatigue), PAIN (Little achy), NAUSEA (Little nausea), PYREXIA (Low grade fever) and FEELING ABNORMAL (feeling abnormal) had resolved.            Concomitant product use was not provided by the reporter. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events  a causal relationship cannot be excluded.
Patient having L arm pain since Dec. after she got her tetanus shot. Pt states her arm never stopped hurting but is slowly getting better. Pt has full mobility of arm with sharp pain with some motions. Pt has been stretching to make it feel betting. This is the pt's first time being seen.  Pt noted two episodes of 'popping' in the area of the injection after which her pain improved in stages.  She now notes restriction in specific movements of her shoulder, specifically full abduction and flexion on the left side.  Some lingering discomfort is still at the site as well.  Pt with prior tetanus injections without side effects.